Rockville, Feb. 20, 2023 (GLOBE NEWSWIRE) -- The global oxidative stress assays market is valued at US$ 1.05 billion in 2023 and is predicted to reach USD 2.49 billion by 2033, as per a new industry analysis by Fact.MR, a market research and competitive intelligence provider.
Oxidative stress happens when a cell or organism produces an excessive amount of oxygen-derived free radicals, which overwhelms the natural antioxidant defences of the organism. Proteins, lipids, and nucleic acids suffer oxidative damage as a result, which can accelerate the development of cancer as well as cardiovascular and neurological conditions, ischemia, diabetes, and asthma. These assays aid in identifying oxidative stress.
Download Sample Copy of This Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=8374
Rapid development of the pharmaceutical and biotechnology sectors is a key factor fuelling the growth of the global oxidative stress assays market.
- BioProcess International estimates that the global sales of biopharmaceuticals were valued at US$ 300 million in 2021 and are growing at a rate of 12% annually. Also, over the next ten years, it is anticipated that the global pharma market will grow at a phenomenal rate.
Recently, it has been observed that biotech companies’ interest in cell concepts is increasing. High-content screening improvements are being offered by several market players. Growing R&D spending plans on healthcare are creating new paths for advancements in medical science. Furthermore, the increasing interest in chronic inflammatory mechanisms among lab researchers is expected to boost sales growth.
Key Takeaways from Market Study
- The global oxidative stress assays market is expected to increase rapidly at a CAGR of 9% from 2023 to 2033.
- Japan’s market is predicted to expand at a CAGR of 8% during the forecast period.
- Demand for consumables is predicted to surge at a CAGR of 9.5% during the forecast period.
- Sales of oxidative stress assays in Germany are predicted to rise at a CAGR of 6.5% from 2023 to 2033.
Key Companies Profiled
- Abcam PLC
- AMS Biotechnology (Europe) Ltd. (AMSBIO)
- Biovision Inc.
- Cell Biolabs, Inc.
- Enzo Biochem, Inc.
- Merck KgaA
- MilliporeSigma
- Oxford Biomedical Research, Inc.
- Promega Corporation
- Qiagen NV
- Thermo Fisher Scientific, Inc
Get Customization on this Report for Specific Research Solutions –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8374
Competitive Landscape
Key players in the oxidative stress assays market are focusing on the advancement of assay products. To maintain their market position and earn more, some of the leading companies are concentrating on regional expansion, local supply, changes in pricing trends, product standards, and more.
- In July 2021, Immuchrom GmbH and Ilex Life Sciences inked a collaboration agreement for the commercialization of gastrointestinal biomarker assays in North America. Immuchrom is a German researcher and manufacturer of photometric assays, immunoassays, and HPLC applications with a focus on oxidative stress, gastrointestinal disease, cardiovascular disease, and calcium and bone metabolism.
- The Photo-oxidation Resistant DCFH-DA ROS Assay Kit was introduced in June 2022 by Dojindo, in Japan.
- FusionPlex Dx and LiquidPlex Dx were launched by Invitae in February 2022 in Europe. FusionPlex Dx is designed to be utilized as a CDx to help identify patients with NSCLC who have ROS proto-oncogene 1 (ROS1) fusions and other conditions that might improve from targeted therapy.
Key Segments of Oxidative Stress Assays Industry Research
By Offering:
- Consumables
- Instruments
- Services
- By Test Type:
- Antioxidant Capacity Assays
- Ascorbic Acid Assays
- Glutathione Assays
- Cell-based Exogenous Antioxidant Assays
- Indirect Assays
- Lipid-based Assays
- Nucleic Acid-based Assays
- Protein-based Assays
- Enzyme-based Assays
- Reactive Oxygen Species-based Assays
- By Technology:
- ELISA
- Chromatography
- Flow Cytometry
- Microscopy,
- High-content Screening
- Label-free Detection
- By Disease:
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Cancer
- Asthma
- By End User:
- Pharma & Biotech Companies
- Academic Research Institutes
- Clinical Laboratories
- Contract Research Organizations
- By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Quick Buy: Oxidative Stress Assays Market Report –
https://www.factmr.com/checkout/8374
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global oxidative stress assays market, presenting historical demand data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.
The study divulges essential insights on the market on the basis of offering (consumables, instruments, services), test type (antioxidant capacity assays, ascorbic acid assays, glutathione assays, cell-based exogenous antioxidant assays, indirect assays, lipid-based assays, nucleic acid-based assays, protein-based assays, enzyme-based assays, reactive oxygen species-based assays), technology (ELISA, chromatography, flow cytometry, microscopy, high-content screening, label-free detection), disease (cardiovascular diseases, diabetes, respiratory diseases, cancer, asthma), and end user (pharma & biotech companies, academic research institutes, clinical laboratories, contract research organizations), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Check out more related studies published by Fact.MR Research:
Cardiopulmonary Stress Testing Systems Market: The global cardiopulmonary stress testing systems market is forecasted to rise at a CAGR of 5.2% from 2023 to 2033. In 2023, the market is valued at US$ 6 billion and is thus estimated to reach a size of US$ 10 billion by the end of 2033.
Lateral Flow Assays Market: The global sales of Lateral Flow Assay in 2021 was held at US$ 7.2 Bn. With 4.7%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.
Cell Viability Assays Market: Cell viability assays are classified strategies and technologies used to determine the strength of the cell in response to any drug tested. Cell viability assays are tested on an organ, cell, or tissue remains in cases.
Fluoro Enzymatic Assays Market: Fluoro enzymatic assays, a biochemical procedure used mainly in immunology to detect the presence of an antigen or an antibody in a sample. Fluoro enzymatic assays is used as a diagnostic tool in pathology and medicine, as well as a quality-control test across industries.
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Connect to Author: Mr. Shambhu Nath Jha
Email : shambhu@factmr.com
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | YouTube
